Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2008
11/06/2008US20080275106 Anticancer and Antiprotozoal Dihydroartemisinene and Dihydroartemisitene Dimers with Desirable Chemical Functionalities
11/06/2008US20080275097 Non-nucleoside reverse transcriptase inhibitors
11/06/2008US20080275081 Novel thrombomodulin expression promoters
11/06/2008US20080275063 C-{4-[6-(2-Ethoxy-phenyl)-pyrimidin-4-ylamino]-phenyl}-N-propyl-methanesulfonamide; antiinflammatories, antiproliferatives, analgesics; cardiovascular disorders, neurodegenerative diseases; immunotherapy
11/06/2008US20080275039 Geldanamycin Derivatives and the Method for Biosynthesis Thereof
11/06/2008US20080275033 Administering Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy
11/06/2008US20080275032 Pyridazinone compounds
11/06/2008US20080275018 Antibacterial amide-macrocycles v
11/06/2008US20080275007 Charged phospholipid compositions and methods for their use
11/06/2008US20080275004 N-Substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
11/06/2008US20080275003 Phospholipase inhibitor; prevention or therapy of microbial infection; bactericides; fungicides; viricides; parasiticides; using quaternary or phosphonium group containing compounds
11/06/2008US20080274998 Adjust biological activity of moesin by binding; parasiticides; bactericides; central nervous system disorders; Down's syndrome; antiinflamamtory agents; anticancer agents; autoimmune diseases; skin disorders; gastrointestinal disorders
11/06/2008US20080274992 Vectors encoding immunogens; human t-cell leukemia,lymphoma virus vaccine
11/06/2008US20080274988 Microarray-Mediated Diagnosis of Herpes Virus Infection by Monitoring Host's Differential Gene Expression Upon Infection
11/06/2008US20080274987 Novel alpha glucosidase activator, pulicarside 1
11/06/2008US20080274954 Novel protein; rho genes rho proteins; guanosine triphosphate binding proteins; antibody against the protein encodes polynucleotide; detection; determinating esophagual cancer
11/06/2008US20080274215 Composition for treatment of cold and flu
11/06/2008US20080274214 Medicament For The Prevention and Treatment Of Influenza
11/06/2008US20080274212 Extract of Tinospora cordifolia; immunoadjuvant; chronic recurrent urinary tract infections; nephrotic syndrome; Glomerulonephritis
11/06/2008US20080274211 Methods and Compositions for Controlling Micororganism Populations in the Digestive System of Animals
11/06/2008US20080274163 Nose and throat anti-influenza solution and method of use
11/06/2008US20080274153 Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations
11/06/2008US20080274145 whole cell or acellular vaccines against pathogenic Gram negatives such as Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica
11/06/2008US20080274144 Genetically engineered or synthetically produced HCV (hepatitis C virus) E1 envelope proteins or parts thereof comprising disulfides between specific cysteine residues; viral-like particles; biodrugs
11/06/2008US20080274143 Chloroplasts Engineering to Express Pharmaceutical Proteins
11/06/2008US20080274142 Hinge (hydrophobic pocket) region mutation attenuation; decreased viscerotropism; vaccines
11/06/2008US20080274141 Animal cells and processes for the replication of influenza viruses
11/06/2008US20080274139 Attenuated microorganisms for the treatment of infection
11/06/2008US20080274135 Measuring Degree of Polymerisation for Meningococcal Capsular Saccharides That Contain Sialic Acid
11/06/2008US20080274131 Molecular antigen arrary
11/06/2008US20080274122 Plks as Modifiers of the Beta Catenin Pathway and Methods of Use
11/06/2008US20080274100 Chemokine receptors CCR5 or CXCR4 specific immunoglobulins for use in prevention and treatment of human immunodeficiency syndrome viral infection
11/06/2008US20080274085 Nutrient broth comprising bifidobacterium for use as therapeutic in treatment of gastrointestinal disorders
11/06/2008US20080274083 Antiviral Resistance Mutants and Applications Thereof
11/06/2008US20080274082 Oximyl hydroxyamic analogs as hepatitis c virus protease inhibitor
11/06/2008US20080274080 Aza-peptide macrocyclic hepatitis c serine protease inhibitors
11/06/2008US20080274063 Supercritical CO2 liquorice extract anti-microbial and anti-inflammatory isolates and products made there from
11/06/2008US20080273660 Compositions and Methods for Modulating DNA Repair
11/06/2008DE102007021149A1 Preparing prenylated aromatic compounds, useful in pharmacy and as antibiotic, comprises incubating an aromatic substrate and a prenylating substance with prenyltransferase
11/06/2008CA2688624A1 Biocidic medical devices, implants and wound dressings
11/06/2008CA2685473A1 Treatment of virally induced lesions
11/06/2008CA2685269A1 Carbohydrate-lipid constructs and their use in preventing or treating viral infection
11/06/2008CA2685247A1 New 4,8-diphenyl-polyazanaphthalene derivatives
11/06/2008CA2685136A1 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
11/06/2008CA2685124A1 Products for altering il-33 activity and methods therefor
11/06/2008CA2684185A1 N-halogenated amino acid formulations and methods for cleaning and disinfection
11/06/2008CA2684098A1 N-halogenated amino acid formulations
11/06/2008CA2682889A1 Antibodies that bind both il-17a and il-17f and methods of using the same
11/06/2008CA2672298A1 Fused pyridine compounds useful in the prophylaxis or treatment of viral infections
11/06/2008CA2667621A1 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production
11/05/2008EP1988093A1 Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
11/05/2008EP1988087A1 Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of autoimmune diseases
11/05/2008EP1987842A1 Cell proliferation inhibitor
11/05/2008EP1987841A1 Use of a lipopeptide or lipoprotein as adjuvans in therapeutic or prophylactic vaccination
11/05/2008EP1987830A1 Stabilized pharmaceutical composition
11/05/2008EP1987825A1 Pharmaceutical composition comprising oseltamivir phosphate
11/05/2008EP1987823A1 Condensation aerosol containing zaleplon for inhalation
11/05/2008EP1987055A1 Novel antimicrobial peptides and use thereof
11/05/2008EP1987038A2 Hcv ns5b inhibitors
11/05/2008EP1987036A1 Hetero-bycyclic antiviral compounds
11/05/2008EP1987035A1 Heterocyclic antiviral compounds
11/05/2008EP1987025A1 Benzoxazinone and benzoxazepinone oxazolidinones as antibacterial agents
11/05/2008EP1986688A2 Methods of using antibodies against human il-22
11/05/2008EP1986654A2 Substituted taraxastanes useful for treating viral infections
11/05/2008EP1986637A1 Sulfonamide derivatives for the treatment of bacterial infections
11/05/2008EP1986626A1 Intravenous antiviral treatments
11/05/2008EP1986620A1 Methods and compositions for bactericide, bacteriostatic and anti-inflammation
11/05/2008EP1986604A1 Aerosol and use thereof
11/05/2008EP1768665B1 Peptidomimetic inhibitors of hiv protease
11/05/2008EP1604660B1 Medicinal composition for treating infection with drug-resistant staphylococcus aureus
11/05/2008EP1597258B1 Novel purine derivatives, preparation method thereof, application of same as medicaments, pharmaceutical compositions and novel use
11/05/2008EP1534276B1 Non-nucleoside reverse transcriptase inhibitors
11/05/2008EP1505945B1 Substituted cycloalkyl p1' hepatitis c virus inhibitors
11/05/2008EP1448215B1 Use of laminarin in the treatment of cancer
11/05/2008EP1363937B1 Immunomodulating agents from parasitic worms and method for isolation thereof
11/05/2008EP1233782B1 Eliciting hcv-specific antibodies
11/05/2008EP1196193B1 Interleukin-1 mutein useful as vaccine adjuvant
11/05/2008EP1150712B1 Human papilloma virus vaccine formulations
11/05/2008EP0994724B1 Methods and compositions for impairing multiplication of hiv-1
11/05/2008CN101300355A Chimeric antigen containing hepatitis c virus polypeptide and Fc fragment for eliciting an immune response
11/05/2008CN101300250A Heterocycles substituted pyridine derivatives and antifungal agent containing thereof
11/05/2008CN101300248A Phosphonated fluoroquinolones, antibacterial analogs thereof, and methods for the prevention and treatment of bone and joint infections
11/05/2008CN101300027A Secretory IgA and IgG antibodies-inducing agent
11/05/2008CN101298473A Conserved neisserial antigens
11/05/2008CN101298471A Epitope capable of exciting human body anti-mycobacterium tuberculosis protective immunity reaction and use thereof
11/05/2008CN101298467A Preparation of anti-newcastle disease virus transfer factor
11/05/2008CN101298456A Cephalosporin derivate containing pyrrolidinezolo piperazinium
11/05/2008CN101298455A Cephalosporin derivate containing triazolo pyridazinium
11/05/2008CN101298454A Cephalosporin derivate containing pyrazolo triazinium
11/05/2008CN101298453A Cephalosporin derivatives containing trizolopyrimidine
11/05/2008CN101298452A Preparing methods and uses of S-(-)-nadifloxacin and water soluble salt thereof
11/05/2008CN101297968A Preparation of pig serum immunoglobulin microsphere novel dosage form
11/05/2008CN101297967A Novel use of staphylococcus enterotoxin A gene
11/05/2008CN101297964A Preparation of chicken thymosin microsphere novel dosage form
11/05/2008CN101297962A Preparation of pig interferon novel dosage form
11/05/2008CN101297961A Preparation of dog interferon novel dosage form
11/05/2008CN101297960A Preparation of chicken interferon novel dosage form
11/05/2008CN101297959A Preparation of chicken interleukin-2 microsphere novel dosage form
11/05/2008CN101297958A Medicament composition for preventing and treating colibacillosis of chicken
11/05/2008CN101297953A Chinese medicine preparation for treating avian influenza and preparation thereof